COMMISSION APPROVES JLL PARTNERS AND KONINKIJKE DSM JOINT VENTURE
February 1st, 2014
THE CREATION of a pharmaceutical joint venture by JLL Partners, of the USA, and Koninkijke DSM, of the Netherlands, has been approved by the European Commission, without imposing conditions. Private equity firm JLL and health and food company DSM will each transfer some of their pharmaceutical businesses to the joint venture. It will focus on contract manufacturing outsourcing, active pharmaceutical ingredients and pharmaceutical product development services. A Commission note said the proposed acquisition “would not raise competition concerns”, because ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.